Macomics Brings on Five Additional Advisors with Internationally Renowned Immunology and Clinical Oncology Expertise
January 24, 2022
Edinburgh and Cambridge, UK, 24 January 2022 – Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, announces today that it has added